Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Sirolimus

4

I.m ILD with a granulomatous component

1
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
MTOR inhibitors
5

Publications

[Drug-induced pneumonitis due to sirolimus: an interaction with atorvastatin?].
Revue des maladies respiratoires 2012 Jan;29;64-9 2012 Jan
Pulmonary toxicity associated with sirolimus treatment in kidney transplantation.
Transplantation proceedings 2006 Oct;38;2438-40 2006 Oct
Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate.
Chest 2006 Jun;129;1718-21 2006 Jun
Patterns of pulmonary complications associated with sirolimus.
Respiration; international review of thoracic diseases 2006;73;367-74 2006
Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients.
Transplantation 2001 Sep 15;72;787-90 2001 Sep 15

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies